Cardinal Health, Inc. (CAH)

Market Cap	36.11B
Revenue (ttm)	222.29B
Net Income (ttm)	1.56B
Shares Out	238.68M
EPS (ttm)	6.38
PE Ratio	23.44
Forward PE	16.95
Dividend	$2.02 (1.33%)
Ex-Dividend Date	Apr 1, 2025

Volume	493,727
Open	150.73
Previous Close	149.53
Day's Range	150.72 - 152.69
52-Week Range	93.17 - 150.12
Beta	0.67
Analysts	Buy
Price Target	143.80 (-4.94%)
Earnings Date	May 1, 2025

About CAH

Cardinal Health, Inc. operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. The company operates in two segments: Pharmaceutical and Specialty Solutions, and Global Medical Products and Distribution. It distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare...

• Industry: Medical Distribution
• Sector: Healthcare
• Founded: 1979
• Employees: 48,900
• Stock Exchange: NYSE
• Ticker Symbol: CAH
• Website: https://www.cardinalhealth.com

Financial Performance

In 2024, Cardinal Health's revenue was $226.83 billion, an increase of 10.66% compared to the previous year's $204.98 billion. Earnings were $852.00 million, an increase of 158.18%.

Analyst Forecast

According to 15 analysts, the average rating for CAH stock is "Buy." The 12-month stock price forecast is $143.8, which is a decrease of -4.94% from the latest price.

Price Target

$143.8

(-4.94% downside)

Analyst Consensus: Buy